Table 4 Submicroscopic aberrations with clinical relevance by SNP array analysis.

From: Etiologic evaluation and pregnancy outcomes of fetal growth restriction (FGR) associated with structural malformations

Case number

Ultrasound findings

Gestational age at FGR first diagnosed (weeks)

Karyotyping results

CMA results

Type of aberration/size

Inheritance

Related syndrome/pathogenic classification

Pregnancy outcome

1

FGR, VSD

17

46,XY

arr[GRCh37] 3q26.33q27.2(182,374,672–185,041,523) × 1

del/2.6Ā Mb

De novo

Pathogenic

TOP

2

FGR, VSD, pulmonary valve stenosis with tricuspid valve insufficiency

21

46,XX

arr[GRCh37] 15q24.1q24.2(72,965,465–75,567,135) × 1

del/2.6Ā Mb

De novo

15q24 Microdeletion Syndrome/Pathogenic

TOP

3

FGR, aortic coarctation, increased cardiothoracic ratio, pericardial effusion, fetal NF thickening, fetal spinal curvature increased

21

46,XY,inv(11)(p15q21)dn

arr[GRCh37] 5q22.3q23.1(113,627,122–116,240,273) × 1, 8q21.11q21.13(74,350,927–81,710,386) × 1

5: del/2.6Ā Mb

8: del/7.3Ā Mb

De novo

8q21.11 Microdeletion Syndrome/Pathogenic

Still birth

4

FGR, VSD, aortic stenosis; Hypoplastic or absent left kidney

23

46,XY

arr[GRCh37] 16q23.2q24.3(79,800,878–90,146,366) hmz, 16p13.3p12.3(94,807–19,302,326) hmz [upd(16)mat]

LOH/10.3Ā Mb, 19.2Ā Mb

De novo

Pathogenic

TOP

5

FGR,VSD

31

46,XY

arr[GRCh37] 22q11.21(18,648,855–21,800,471) × 1

del/3.1Ā Mb

De novo

DiGeorge Syndrome or velocardiofacial syndrome /Pathogenic

TOP

  1. FGR, fetal growth restriction; VSD, ventricular septal defects.